Prevalence and correlates of needle-sharing among new and long-term injection drug users in Southwest China

Substance Use and Misuse

Volumn 45, Issue 14, 2010, Pages 2503-2523

  Zhang, Linglin ^a   Li, Jie ^b   Lai, Wenhong ^a   Feng, Liao ^a   Zeng, Yali ^a   Liu, Li ^a   Hu, Ying ^a   Liu, Jianbo ^c   Zhang, Xiaolin ^c   Wu, Pingsheng ^d   Vermund, Sten H ^d   Jia, Yujiang ^d  

^a SICHUAN CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^b CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^c HEBEI MEDICAL UNIVERSITY   (China)

^d VANDERBILT UNIVERSITY   (United States)

Author keywords

China; condom use; Injection drug user; needle sharing; risk factor

Indexed keywords

ADULT; ARTICLE; CHINA; CROSS-SECTIONAL STUDY; DRUG ABUSE; FEMALE; HEALTH BEHAVIOR; HIGH RISK BEHAVIOR; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTERVIEW; MALE; RISK FACTOR; STATISTICS; SUBSTANCE ABUSE;

ADULT; CHINA; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH BEHAVIOR; HIV INFECTIONS; HUMANS; INTERVIEWS AS TOPIC; MALE; NEEDLE SHARING; RISK FACTORS; RISK-TAKING; SUBSTANCE ABUSE, INTRAVENOUS; YOUNG ADULT;

EID: 78049466520     PISSN: 10826084     EISSN: 15322491     Source Type: Journal    
DOI: 10.3109/10826084.2010.487234     Document Type: Article

References (63)

1. Bao, Y. G., Zhang, Y. H. (2007). Risk factors on heroin lapse of methadone maintenance treatment outpatients. Practical Preventive Medicine, 14(6):1923-1925.
2. Becker Buxton, M., Vlahov, D., Strathdee, S. A., Des Jarlais, D. C., Morse, E. V., Ouellet, L., et al. (2004). Association between injection practices and duration of injection among recently initiated injection drug users. Drug and Alcohol Dependence, 75(2):177-183.
3. Bryant, J., Treloar, C. (2007). The gendered context of initiation to injecting drug use: evidence for women as active initiates. Drug and Alcohol Review, 26(3):287-293.
4. Bryant, J., Treloar, C. (2008). Initiators: an examination of young injecting drug users who initiate others to injecting. AIDS and Behaviorb, 12(6):885-890.
5. Chen, K. L., Hao, C., Yuan, Y. H., Xie, L. Z., Wu, J., Xia, Y., et al. (2006). Qualitative study of factors contributed to retention in a community-based methadone maintenance treatment among heroin users. Chinese Journal of Drug Dependence, 12(6):315-319.
6. China CDC (2008). National HIV/AIDS surveillance report. Beijing, China: Center for Disease Control and Prevention.
7. China Ministry of Health, and UN Theme Group on HIV/AIDS in China (2008). A joint assessment of HIV/AIDS prevention, treatment and care in China (2007). Retrieved December 28, 2009, from http://www.chinaids.org.cn/n443289/n443292/ 6438.html
8. Chitwood, D. D., Comerford, M., Kitner, K. R., Palacios, W., Sanchez, J. (2001). A comparison of HIV risk behaviors between new and long-term injection drug users. Substance Use and Misuse, 36(1-2):91-111. (Web of Science)
9. Choi, S. Y., Cheung, Y. W., Jiang, Z. Q. (2007). Ethnicity and risk factors in needle sharing among intravenous drug users in Sichuan Province, China. AIDS Care, 19(1):1-8. (Web of Science)
10. Chu, T. X., Levy, J. A. (2005). Injection drug use and HIV/AIDS transmission in China. Cell Research, 15(11-12):865-869. (Web of Science)
11. Day, C. A., Ross, J., Dietze, P., Dolan, K. (2005). Initiation to heroin injecting among heroin users in Sydney, Australia: cross-sectional survey. Harm Reduction Journal, 2(1):2.
12. Des Jarlais, D. C., Friedman, S. R., Perlis, T., Chapman, T. F., Sotheran, J. L., Paone, D., et al. (1999). Risk behavior and HIV infection among new drug injectors in the era of AIDS in New York City. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 20(1):67-72. (Web of Science)
13. Des Jarlais, D. C., Perlis, T., Arasteh, K., Torian, L. V., Hagan, H., Beatrice, S., et al. (2005). Reductions in hepatitis C virus and HIV infections among injecting drug users in New York City, 1990-2001. AIDS, 19(Suppl 3):S20-S25.
14. Doherty, M. C., Garfein, R. S., Monterroso, E., Brown, D., Vlahov, D. (2000). Correlates of HIV infection among young adult short-term injection drug users. AIDS, 14(6):717-726. (Pubitemid 30229351)
15. Downing, M., Knight, K., Reiss, T. H., Vernon, K., Mulia, N., Ferreboeuf, M., et al. (2001). Drug users talk about HIV testing: motivating and deterring factors. AIDS Care, 13(5):561-577. (Web of Science)
16. Ford, K., Wirawan, D. N., Sumantera, G. M., Sawitri, A. A., Stahre, M. (2004). Voluntary HIV testing, disclosure, and stigma among injection drug users in Bali, Indonesia. AIDS Education and Prevention, 16(6):487-498. (Web of Science)
17. Gao, Q., Cheng, H., Ding, L. (2008). Characteristics of methadone maintenance treatment patients' social network and status of sustainment. Acta Universitis Medicinalis Nanjing (Social Science), 32(3):230-233.
18. Garfein, R. S., Doherty, M. C., Monterroso, E. R., Thomas, D. L., Nelson, K. E., Vlahov, D. (1998). Prevalence and incidence of hepatitis C virus infection among young adult injection drug users. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 18 (Suppl 1):S11-S19.
19. Garten, R. J., Lai, S., Zhang, J., Liu, W., Chen, J., Vlahov, D., et al. (2004). Rapid transmission of hepatitis C virus among young injecting heroin users in Southern China. International Journal of Epidemiology, 33(1):182-188.
20. Hacker, M. A., Friedman, S. R., Telles, P. R., Teixeira, S. L., Bongertz, V., Morgado, M. G., et al. (2005). The role of "long-term" and "new" injectors in a declining HIV/AIDS epidemic in Rio de Janeiro, Brazil. Substance Use and Misuse, 40(1):99-123. (Web of Science)
21. Hao, C., Wu, J., Ruan, Y., Yao, M., Yang, X., Li, L., et al. (2007). Factors associated with retention in a community-based methadone maintenance treatment among heroin addicts. Chinese Journal of Preventive Medicine, 41(4):250-253.
22. Hao, W., Xiao, S., Liu, T., Young, D., Chen, S., Zhang, D., et al. (2002). The second national epidemiological survey on illicit drug use at six high-prevalence areas in China: prevalence rates and use patterns. Addiction, 97(10):1305-1315. (Web of Science)
23. Jia, Y., Lu, F., Sun, X., Vermund, S. H. (2007). Sources of data for improved surveillance of HIV/AIDS in China. Southeast Asian Journal of Tropical Medicine and Public Health, 38(6):1041-1052.
24. Jia, Y., Lu, F., Zeng, G., Sun, X., Xiao, Y., Lu, L., et al. (2008a). Predictors of HIV infection and prevalence for syphilis infection among injection drug users in China: community-based surveys along major drug trafficking routes. Harm Reduction Journal, 5:29.
25. Jia, Y., Sun, J., Fan, L., Song, D., Tian, S., Yang, Y., et al. (2008b). Estimates of HIV prevalence in a highly endemic area of China: Dehong prefecture, Yunnan Province. International Journal of Epidemiology, 37(6):1287-1296. (Web of Science)
26. Jia, Y., Zhang, L., Li, J., Lai, W. H., Wu, P., Bahr, W., et al. (in press). HIV, syphilis infections, and associated high-risk behaviors among female drug users in Southern China. International Journal of Infecious Diseases.
27. Judd, A., Hickman, M., Jones, S., McDonald, T., Parry, J. V., Stimson, G. V., et al. (2005). Incidence of hepatitis C virus and HIV among new injecting drug users in London: prospective cohort study. British Medical Journal, 330(7481):24-25.
28. Lau, J. T., Cheng, F., Tsui, H. Y., Zhang, Y., Zhang, J., Wang, N., et al. (2007). Clustering of syringe sharing and unprotected sex risk behaviors in male injecting drug users in China. Sexually Transmitted Diseases, 34(8):574-582.
29. Lau, J. T., Tsui, H. Y., Zhang, Y., Cheng, F., Zhang, L., Zhang, J., et al. (2008). Comparing HIV-related syringe-sharing behaviors among female IDU engaging versus not engaging in commercial sex. Drug and Alcohol Dependence, 97(1-2):54-63.
30. Liao, M., Jiang, Z., Zhang, X., Kang, D., Bi, Z., Liu, X., et al. (in press). Syphilis infection and metham-phetamine use among female sex workers in Shandong Province, China. Sexually Transmitted Diseases.
31. Liu, H., Grusky, O., Li, X., Ma, E. (2006). Drug users: a potentially important bridge population in the transmission of sexually transmitted diseases, including AIDS, in China. Sexually Transmitted Diseases, 33(2):111-117. (Web of Science)
32. Liu, J. B. (2007). Cox regression analysis of retention time and factors of methadone maintenance treatment. Journal of China AIDS/STD Prevention and Control, 13(2):160-161.
33. Liu, L., Luan, R., Yang, W., Zhang, L., Zhang, J., Nan, L., et al. (2009a). Projecting dynamic trends for HIV/AIDS in a highly endemic area of China: estimation models for Liangshan prefecture, Sichuan Province. Current HIV Research, 7(4):390-397. (Web of Science)
34. Lu, F., Jia, Y., Sun, X., Wang, L., Liu, W., Xiao, Y., et al. (2009). Prevalence of HIV infection and predictors for syphilis infection among female sex workers in southern China. Southeast Asian Journal of Tropical Medicine and Public Health, 40(2):263-272. (Web of Science)
35. Lu, F., Wang, N., Wu, Z., Sun, X., Rehnstrom, J., Poundstone, K., et al. (2006). Estimating the number of people at risk for and living with HIV in China in 2005: methods and results. Sexually Transmitted Infections, 82(Suppl 3):87-91. (Web of Science)
36. Maher, L., Li, J., Jalaludin, B., Chant, K. G., Kaldor, J. M. (2007). High hepatitis C incidence in new injecting drug users: a policy failure? Australian and New Zealand Journal of Public Health, 31(1):30-35.
37. Mao, W., Zhang, L., Xiao, Y., Jiang, B., Zhu, J., Ma, W., et al. (in press). Barriers and facilitators to voluntary HIV counseling and testing among injection drug users and their attitudes toward the peer opinion leader-led HIV testing through diffusion of positive AIDS care messages. Chinese Journal of Epidemiology.
38. Miller, M., Mella, I., Moi, H., Eskild, A. (2003). HIV and hepatitis C virus risk in new and longer-term injecting drug users in Oslo, Norway. Journal of Acquired Immune Deficiency Syndromes, 33(3):373-379.
39. Muga, R., Sanvisens, A., Bolao, F., Tor, J., Santesmases, J., Pujol, R., et al. (2006). Significant reductions of HIV prevalence but not of hepatitis C virus infections in injection drug users from metropolitan Barcelona: 1987-2001. S29-S33. (Web of Science)
40. Platt, L., Rhodes, T., Hickman, M., Mikhailova, L., Lisetsky, K., Sarang, A., et al. (2008). Changes in HIV prevalence and risk among new injecting drug users in a Russian city of high HIV prevalence. Journal of Acquired Immune Deficiency Syndromes, 47(5):623-631.
41. Roy, E., Haley, N., Leclerc, P., Cedras, L., Boivin, J. F. (2002). Drug injection among street youth: the first time. Addiction, 97(8):1003-1009.
42. Ruan, Y., Qin, G., Liu, S., Qian, H., Zhang, L., Zhou, F., et al. (2005). HIV incidence and factors contributed to retention in a 12-month follow-up study of injection drug users in Sichuan Province, China. Journal of Acquired Immune Deficiency Syndromes, 39(4):459-463.
43. Santibanez, S. S., Garfein, R. S., Swartzendruber, A., Purcell, D. W., Paxton, L. A., Greenberg, A. E. (2006). Update and overview of practical epidemiologic aspects of HIV/AIDS among injection drug users in the United States. Journal of Urban Health, 83(1):86-100. (Web of Science)
44. Shi, S., Huang, Y. S., Li, X. (2008). Correlation factors influencing the effect of methadone maintenance treatment. Chinese Journal of Drug Dependence, 17(1):56-60.
45. Sichuna Provincial CDC (2007). HIV/AIDS epidemics in Sichuan Province. Sichuan Provincial AIDS Prevention and Care Information, 6(2):1-6.
46. Sichuan Provincial CDC (2007). Work progress Report on the Sichuan AIDS treatment and prevention. Sichuan Provincial AIDS Prevention and Care Information, 6(2):7-39.
47. Sichuan Provincial CDC (2009). Report on HIV/AIDS prevention and treatment. Chengdu, China: Institute for AIDS/STD Control and Prevention.
48. Sullivan, S. G., Wu, Z. (2007). Rapid scale up of harm reduction in China. International Journal of Drug Policy, 18(2):118-128. (Web of Science)
49. Sutton, A. J., Gay, N. J., Edmunds, W. J., Hope, V. D., Gill, O. N., Hickman, M. (2006). Modelling the force of infection for hepatitis B and hepatitis C in injecting drug users in England and Wales. BMC Infectious Diseases, 6:93.
50. Tang, Y. L., Zhao, D., Zhao, C., Cubells, J. F. (2006). Opiate addiction in China: current situation and treatments. Addiction, 101(5):657-665. (Web of Science)
51. Uuskula, A., Kals, M., Rajaleid, K., Abel, K., Talu, A., Ruutel, K., et al. (2008). High-prevalence and high-estimated incidence of HIV infection among new injecting drug users in Estonia: need for large-scale prevention programs. Journal of Public Health (Oxford), 30(2):119-125. (Web of Science)
52. Vermund, S. H., Wilson, C. M. (2002). Barriers to HIV testing\-where next? Lancet, 360(9341):1186-1187. (Web of Science)
53. Wang, J., Li, F., Mo, L. R., Li, L., Guan, Y., Hao, C., et al. (2007). Factors associated with retention in a community-based methadone maintenance treatment among drug users in Urumqi, Xinjiang Uigur autonomous region. Chinese Journal of Epidemiology, 28(1):37-41.
54. Wu, Z., Detels, R., Zhang, J., Duan, S., Cheng, H., Li, Z., et al. (1996). Risk factors for intravenous drug use and sharing equipment among young male drug users in Longchuan County, south-west China. AIDS, 10(9):1017-1024. (Web of Science)
55. Wu, Z., Luo, W., Sullivan, S. G., Rou, K., Lin, P., Liu, W., Ming, Z. (2007, December). Evaluation of a needle social marketing strategy to control HIV among injecting drug users in PR China. AIDS, 21(suppl 8):S115-122.
56. Wu, Z., Luo, W., Sullivan, S. G., Rou, K., Lin, P., Liu, W., et al. (2007a). Evaluation of a needle social marketing strategy to control HIV among injecting drug users in China. AIDS, 21(Suppl 8):S115-S122. (Web of Science)
57. Wu, Z., Sullivan, S. G., Wang, Y., Rotheram-Borus, M. J., Detels, R. (2007b). Evolution of China's response to HIV/AIDS. Lancet, 369(9562):679-690. (Web of Science)
58. Wu, Z., Sun, X., Sullivan, S. G., Detels, R. (2006). Public health. HIV testing in China. Science, 312(5779):1475-1476. (Web of Science)
59. Xiao, S. Y., Hao, W., Young, D. S. (1996). Epidemiological survey on illicit drug use in five high prevalence areas in China. Part I: demographics and prevalence rates. Zhouguo Jing Shen Wei Sheng Za Zhi, 10;278-280.
60. Xiao, Y., Kristensen, S., Sun, J., Lu, L., Vermund, S. H. (2007). Expansion of HIV/AIDS in China: lessons from Yunnan Province. Social Science and Medicine, 64(3):665-675. (Web of Science)
61. Yin, L., Qin, G., Qian, H.Z., Zhu, Y., Hu, W., Zhang, L., et al. (2007). Continued spread of HIV among injecting drug users in southern Sichuan Province, China. Harm Reduction Journal, 4:6.
62. Zhu, J. (2008). Prevalence and incidence of HIV and syphilis among drug users in Xichang County of Sichuan Province. Beijing, China: China Center for Disease Control and Prevention.
63. Zinberg, N. (1984). Drug, set and setting: the basis for controlled intoxicant use. New Haven, CT: Yale University Press.